Tech Stock News
Friday, October 7, 2022
Mind Medicine (MindMed) Inc (NASDAQ: MNMD) recently announced that it has successfully been added to the FTSE Russell 3000® index. Russell 3000® index measures the performance of the largest 3,000 corporate houses in the U.S. The corporate house is a psychedelic-inspired medicine company. Russell indexes are benchmarks for planning and […]
Mind Medicine (MindMed) Inc (NASDAQ: MNMD) closed at $3.52 shedding 5.12%. Certain pain points are limiting the attractiveness of this company. From where we see, it has one of the most diversified psychedelics pipelines as far as R&D, and clinical development in the mental health segment is concerned. With a […]